181. (Journal Article): Reversal of lesions of diabetic nephropathy after pancreas transplantation.

Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M
 
ABSTRACT: BACKGROUND: In patients with type I diabetes mellitus who do not have uremia and have not received a kidney transplant, pancreas transplantation does not ameliorate established les...

182. (Journal Article): Glucose-dependent insulin release from genetically engineered K cells.

Cheung AT, Dayanandan B, Lewis JT, Korbutt GS, Rajotte RV, Bryer-Ash M, Boylan MO, Wolfe MM, Kieffer TJ
 
ABSTRACT: Genetic engineering of non-beta cells to release insulin upon feeding could be a therapeutic modality for patients with diabetes. A tumor-derived K-cell line was induced to produce...

183. (Journal Article): Transcribing pancreas.

Edlund H
 
ABSTRACT: For approximately 30-35 years, our insight into some of the fundamental aspects of pancreas development has been based mainly on two independent studies performed in the 1960s by G...

184. (Journal Article): Tissue culture of human fetal pancreas.

Sandler S, Andersson A, Landstrom AS, Tollemar J, Borg H, Petersson B, Groth CG, Hellerstrom C
 
ABSTRACT: The human fetal pancreas represents a source of insulin-producing beta-cells with a potential for transplantation to diabetic patients. It has previously been shown that such cells...

185. (Journal Article): In vitro study of elements in herbal remedies.

Szentmihalyi K,, Hajdu M, Fodor J, Kotai L, Blazovics A, Somogyi A, Then M.
 
ABSTRACT: Decreased glucose tolerance is a first sign of diabetes mellitus and therefore rigorous control must be taken in carbohydrate and lipid metabolisms. Herbal remedies (lyophilized ex...

186. (Journal Article): "Persistence of Diabetes" - Why Has Research into Type 1 Diabetes not Made Significant Advances?

Sia C, Weinem M
 
ABSTRACT: n/a

187. (Journal Article): Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells.

Zalzman M, Gupta S, Giri R, Berkovich I, Sappal BS, Karnieli O, Zern MA, Fleischer N, Efrat S
 
ABSTRACT: Beta-cell replacement is considered to be the most promising approach for treatment of type 1 diabetes. Its application on a large scale is hindered by a shortage of cells for tran...

188. (Journal Article): The role of GLP-1 in the life and death of pancreatic beta cells.

Perfetti R, Hui H
 
ABSTRACT: Glucagon-like peptide-1 (GLP-1), a peptide hormone produce by intestinal cells, has recently been shown to be capable of modulating islet cell mass. Administration of GLP-1 to rode...

189. (Journal Article): Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human is-lets.

Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R
 
ABSTRACT: The peptide hormone, glucagon-like peptide 1 (GLP-1), has been shown to increase glucose-dependent insulin secretion, enhance insulin gene transcription, expand islet cell mass, an...

190. (Journal Article): The Application of Umbilical Cord Blood Cells in the Treatment of Diabetes Mellitus

Koblas T, Harman SM, Saudek F
 
ABSTRACT: In recent years, human umbilical cord blood (HUCB) has emerged as an attractive tool for cell-based therapy. Although at present the clinical application of HUCB is limited to the ...